-
摘要:
外科手术部位感染(SSI)是外科手术后常见的并发症.在实体器官移植中, 肝移植SSI发生率最高.本文就肝移植受者中SSI的定义、诊断标准、发生时间、发生部位及发生率、病原菌分布、危险因素、预防措施、与术后生存率之间关系等方面进行阐述.针对肝移植术后SSI的发生时间、病原菌种类、危险因素等特点, 实施相应的目标性监测, 采取合理、积极的预防与干预措施, 将SSI发生率降到最低水平, 将会对患者和社会有所裨益.
-
[1] Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory[J]. Clin Microbiol Rev, 1993, 6(4):428-442. doi: 10.1128/CMR.6.4.428 [2] Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infections in acute care hospitals[J]. Infect Control Hosp Epidemiol, 2008, 29(Suppl 1):S51-S61. https://www.ncbi.nlm.nih.gov/pubmed/18840089 [3] Dummer J. Infections in solid organ transplant recipients[M]//Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. Philadelphia:Churchill Livingstone, 2005:3501-3512. http://europepmc.org/articles/PMC172945 [4] Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC)Hospital Infection Control Practices Advisory Committee[J]. Am J Infect Control, 1999, 27(2):97-134, 196. doi: 10.1016/S0196-6553(99)70088-X [5] 医院感染诊断标准(试行)[J].中华医学杂志, 2001, 81(5):61-67. http://www.cnki.com.cn/Article/CJFDTotal-ZHYX200105025.htmDiagnostic criteria for nosocomial infections(proposed)[J]. Natl Med J China, 2001, 81(5):61-67. http://www.cnki.com.cn/Article/CJFDTotal-ZHYX200105025.htm [6] Iinuma Y, Senda K, Fujihara N, et al. Surgical site infection in living-donor liver transplant recipients:a prospective study[J]. Transplantation, 2004, 78(5):704-709. doi: 10.1097/01.TP.0000130178.17216.28 [7] Hellinger WC, Crook JE, Heckman MG, et al. Surgical site infection after liver transplantation:risk factors and association with graft loss or death[J]. Transplantation, 2009, 87(9):1387-1393. doi: 10.1097/TP.0b013e3181a25133 [8] Freire MP, Soares Oshiro IC, Bonazzi PR, et al. Surgical site infections in liver transplant recipients in the model for end-stage liver disease era:an analysis of the epidemiology, risk factors, and outcomes[J]. Liver Transpl, 2013, 19(9):1011-1019. doi: 10.1002/lt.v19.9 [9] García Prado ME, Matia EC, Ciuro FP, et al. Surgical site infection in liver transplant recipients:impact of the type of perioperative prophylaxis[J]. Transplantation, 2008, 85(12):1849-1854. doi: 10.1097/TP.0b013e3181735407 [10] Kawecki D, Chmura A, Pacholczyk M, et al. Surgical site infections in liver recipients in the early posttransplantation period:etiological agents and susceptibility profiles[J]. Transplant Proc, 2007, 39(9):2800-2806. doi: 10.1016/j.transproceed.2007.08.049 [11] Shi SH, Kong HS, Xu J, et al. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients[J]. Transpl Infect Dis, 2009, 11(5):405-412. doi: 10.1111/tid.2009.11.issue-5 [12] Mrzljak A, Peric Z, Kovacevic V, et al. Rising problem of multidrug-resistant gram-negative bacteria causing bloodstream infections after liver transplantation:how should we handle the issue?[J]. Liver Transpl, 2010, 16(10):1217-1219. doi: 10.1002/lt.v16:10 [13] Kim YJ, Yoon JH, Kim SI, et al. High mortality associated with Acinetobacter species infection in liver transplant patients[J]. Transplant Proc, 2011, 43(6):2397-2399. doi: 10.1016/j.transproceed.2011.06.011 [14] Raghuram A, Restrepo A, Safadjou S, et al. Invasive fungal infections following liver transplantation:incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007)[J]. Liver Transpl, 2012, 18(9):1100-1109. doi: 10.1002/lt.v18.9 [15] Auzinger G. Invasive candidiasis following liver transplantation and surgical complications[J]. Mycoses, 2011, 54(Suppl 4):4-7. https://www.researchgate.net/publication/221718222_Invasive_candidiasis_following_liver_transplantation_and_surgical_complications [16] Pacholczyk M, Lagiewska B, Lisik W, et al. Invasive fungal infections following liver transplantation:risk factors, incidence and outcome[J]. Ann Transplant, 2011, 16(3):14-16. doi: 10.12659/AOT.881989 [17] Hollenbeak CS, Alfrey EJ, Souba WW. The effect of surgical site infections on outcomes and resource utilization after liver transplantation[J]. Surgery, 2001, 130(2):388-395. doi: 10.1067/msy.2001.116666 [18] Hollenbeak CS, Alfrey EJ, Sheridan K, et al. Surgical site infections following pediatric liver transplantation:risks and costs[J]. Transpl Infect Dis, 2003, 5(2):72-78. doi: 10.1034/j.1399-3062.2003.00013.x [19] Asensio A, Ramos A, Cuervas-Mons V, et al. Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant[J]. Liver Transpl, 2008, 14(6):799-805. doi: 10.1002/(ISSN)1527-6473 [20] Park C, Hsu C, Neelakanta G, et al. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation[J]. Transplantation, 2009, 87(7):1031-1036. doi: 10.1097/TP.0b013e31819cc3e6 [21] Hellinger WC, Heckman MG, Crook JE, et al. Association of surgeon with surgical site infection after liver transplantation[J]. Am J Transplant, 2011, 11(9):1877-1884. doi: 10.1111/j.1600-6143.2011.03644.x [22] Kusne S. Regarding the risk for development of surgical site infections and bacterial prophylaxis in liver transplantation[J]. Liver Transpl, 2008, 14(6):747-749. doi: 10.1002/(ISSN)1527-6473 [23] Cruciani M, Mengoli C, Malena M, et al. Antifungal prophylaxis in liver transplant patients:a systematic review and meta-analysis[J]. Liver Transpl, 2006, 12(5):850-858. doi: 10.1002/(ISSN)1527-6473 [24] Cockbain AJ, Goldsmith PJ, Gouda M, et al. The impact of postoperative infection on long-term outcomes in liver transplantation[J]. Transplant Proc, 2010, 42(10):4181-4183. doi: 10.1016/j.transproceed.2010.09.026 -
点击查看大图
计量
- 文章访问数: 153
- HTML全文浏览量: 79
- PDF下载量: 12
- 被引次数: 0
下载:
